Your browser doesn't support javascript.
loading
Effective treatments for paronychia caused by oncology pharmacotherapy.
Goto, Hiroyuki; Yoshikawa, Shusuke; Mori, Keita; Otsuka, Masaki; Omodaka, Toshikazu; Yoshimi, Kosuke; Yoshida, Yuichi; Yamamoto, Osamu; Kiyohara, Yoshio.
Afiliação
  • Goto H; Department of Dermatology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Yoshikawa S; Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, Tottori, Japan.
  • Mori K; Department of Dermatology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Otsuka M; Clinical Research Promotion Unit, Clinical Research Center, Shizuoka Cancer Center, Shizuoka, Japan.
  • Omodaka T; Department of Dermatology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Yoshimi K; Department of Dermatology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Yoshida Y; Department of Dermatology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Yamamoto O; Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, Tottori, Japan.
  • Kiyohara Y; Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, Tottori, Japan.
J Dermatol ; 43(6): 670-3, 2016 Jun.
Article em En | MEDLINE | ID: mdl-26596962
ABSTRACT
Cutaneous adverse events are relatively common in patients being treated with molecular-targeted drugs. Paronychia is one of the cutaneous adverse events that influences the patient's quality of life because of pain, and it often affects anticancer treatments in severe cases. However, there are few effective treatments, especially for severe paronychia. Here, we present our experiences of treatment for paronychia due to oncology pharmacotherapy. Although we treated paronychia with various methods, only corticosteroid ointment and phenol chemical matricectomy significantly improved the paronychia. Dermatologists must perform appropriate and effective treatments for paronychia in order to enable patients to continue anticancer drug treatment without impairing their quality of life.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paroniquia / Soluções Esclerosantes / Corticosteroides / Fenol / Antineoplásicos Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paroniquia / Soluções Esclerosantes / Corticosteroides / Fenol / Antineoplásicos Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article